Journal of Behavioral Addictions
February 3, 2026
Atanas Tannous, Zsolt Demetrovics, Bhavya Chhabra et al.
Gambling disorder (GD) presents significant psychological, financial, and social consequences. Mindfulness-based interventions (MBIs) have emerged as promising adjunctive treatments. However, the evidence base remains heterogeneous. The present systematic review evaluated the current empirical literature on MBIs for GD, focusing on their efficacy, methodological quality, and limitations....
Journal of Behavioral Addictions
March 26, 2024
Pedro Romero, Andrea Czakó, Wim van den Brink et al.
7 citations
Abstract Gambling disorder is a severe mental health and behavioural problem with harmful consequences, including financial, relationship and mental health problems. The present paper initiates discussion on the use of psychedelics combined with psychotherapeutic support as a potential treatment option for people living with a gambling disorder. Recent studies have shown promising results using...
Journal of psychopharmacology (Oxford, England)
June 1, 2020
Annemieke Benschop, Róbert Urbán, Máté Kapitány-fövény et al.
35 citations
New psychoactive substances (NPS) pose a public health threat. Many studies have tried to identify the reasons of NPS use; however, none of them have so far used any standardised measures. The aim of this study was (i) to develop and cross-culturally validate the New Psychoactive Substance Use Motives Measure (NPSMM) and (ii) to compare motives of NPS use across countries and user types. Three...
Psychologia Hungarica Caroliensis
2015
Fruzsina Iszáj, Bea Ehmann, Zsolt Demetrovics
1 citation
Tanulmnyunk clja az volt, hogy megvizsgljuk a pszichedelikus szerhasznlat kreatv alkotk nyelvhasznlatra gyakorolt hatsait. Flig strukturlt interjkat vettnk fel 60 mvszszel
Human Psychopharmacology Clinical and Experimental
March 1, 2012
Ornella Corazza, Fabrizio Schifano, Pierluigi Simonato et al.
157 citations
On the basis of the material available both in the scientific literature and on the web, this paper aims to provide a pharmacological, chemical and behavioural overview of the novel compound methoxetamine. This is a dissociative drug related to ketamine, with a much longer duration of action and intensity of effects. A critical discussion of the availability of information on the web of...
Current Clinical Pharmacology
May 1, 2011
Ornella Corazza, Fabrizio Schifano, Magı́ Farré et al.
98 citations
Based on the material available in both the scientific literature and on the web, the present paper provides an updated pharmacological, chemical, toxicological and behavioural overview of Bromo-Dragonfly (1-(8-bromobenzo[1,2-b;4,5-b']difuran-4-yl)-2-aminopropane; 'B-fly'). B-Fly is a powerful, long lasting, LSD-like, hallucinogenic drug, which has been associated with a number of acute...
Psychopharmacology
April 2011
Fabrizio Schifano, Antonio Albanese, Suzanne Fergus et al.
Recently, those substances deriving from the active ingredient of the Khat plant, cathinone, have been rising in popularity. Indeed, 4-methylmethcathinone (mephedrone; 'meow meow' and others) has been seen by some as a cheaper alternative to other classified recreational drugs. We aimed here at providing a state-of-the-art review on mephedrone history and prevalence of misuse, chemistry,...